An undisclosed, but reliable source told Reuters about the out-of-this-world scheme everyone’s favorite stocks and shares investor, Sahm Adrangi. Reports claim that Mr. Sahm plans on shorting a particular company’s stock before it debuts in the public stock exchange. The insider revealed that Sahm planned on placing a $100 million wager against the stock. The investor presently heads up his super successful hedge fund management firm, Kerrisdale Capital Management. The latter company specializes in lifting distressed energy firms from the brink of annihilation, mortgage finance and stocks and shares investments.
According to Reuters
Adrangi’s successful stint dates back many years gone. A while back the astute market analyst spoke to Reuters and said how he was excited that his company had managed to raise so much capital in little time. He was also ecstatic about the grand reception the market, especially the clients had shown them over the years.
Research, Research, and more Research
The secret behind Kerrisdale Capital Management lies in their ability to dissect the fundamentals of a particular company before pitching it to their investors. After Sahm’s team conducts an in-depth research and analysis, they make videos and compiling reports to send out to their e-mailing lists.
Sahm’s innovative ideas are responsible for transforming the hedge fund management firm into a company worth $500M. They’ve earned most of that huge chunk of money betting against selected stocks and shares, for instance, they recently made a ton of money betting against the pharmaceutical giants, Zafgen and Sage Therapeutics Inc. under Mr. Adrangi, Kerrisdale has seen its stock price go up by a whopping 28% in the span of just five years.
About Sahm Adrangi
Mr. Adrangi founded Kerrisdale Capital Fund in 2009. Back then, the company’s liquidity reserves stood at just one million dollars. Fast forward to 2017 and the investment firm controls and manages a portfolio worth $150M.
Kerrisdale dabbles with a rich variety of investment opportunities, but without a doubt, the company’s mostly known for making accurate short-selling calls on pharmaceutical stocks. Kerrisdale doesn’t charge a penny to anyone interested in reading their latest research findings often posted online. In the past, Kerrisdale Capital Management customers were able to mint millions in profits after the advice of Sahm’s company to buy shares like Lihua International, China-Biotics, and China Marine Food Group. Here’s a link to the officialTwitter profile of Sahm Adrangi. Follow him and stay informed the next time he comes to give a feature presentation talk at a conference in your city.
For details: www.benzinga.com/topic/sahm-adrangi